Design, synthesis, and optimization of balanced dual NK1/NK 3 receptor antagonists

ACS Medicinal Chemistry Letters

Volumn 5, Issue 5, 2014, Pages 550-555

  Hanessian, Stephen ^a   Jennequin, Thomas ^a   Boyer, Nicolas ^a,c   Babonneau, Vincent ^a   Soma, Udaykumar ^a   Mannoury La Cour, Clotilde ^b   Millan, Mark J ^b   De Nanteuil, Guillaume ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c Ra Pharmaceuticals Inc   (United States)

Author keywords

molecular hybridization; peptidomimetic; Schizophrenia

Indexed keywords

NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR ANTAGONIST;

ARTICLE; CATALYST; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; MOLECULAR HYBRIDIZATION; PEPTIDE SYNTHESIS; PHARMACOPHORE; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 84900461848     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400528y     Document Type: Article

References (60)

1. Almeida, T. A.; Rojo, J.; Nieto, P. M.; Pinto, F. M.; Hernandez, M.; Martín, J. D.; Candenas, M. L. Tachykinins and tachykinin receptors: structure and activity relationships Curr. Med. Chem. 2004, 11, 2045
2. Davidson, C.; Lee, T. H.; Ellinwood, E. H. The NK(1) receptor antagonist WIN51708 reduces sensitization after chronic cocaine Eur. J. Pharmacol. 2004, 499, 55
3. Spooren, W.; Riemer, C.; Meltzer, H. Opinion: NK3 receptor antagonists: the next generation of antipsychotics? Nat. Rev. Drug Discovery 2005, 4, 967
4. Dawson, L. A.; Smith, P. W. Therapeutic utility of NK3 receptor antagonists for the treatment of schizophrenia Curr. Pharm. Des. 2010, 16, 344
5. For an example of dual NK1/NK3 antagonists for the treatment of Schizophrenia, see also: Alvaro, G.; Andreotti, A.; Belvedere, S.; Di Fabio, R.; Falchi, A.; Giovannini, R. Pyridine derivatives and their use in the treatment of psychotic disorders. WO2007028654, 2007.
6. Hanessian, S.; Babonneau, V.; Boyer, N.; Mannoury LaCour, C.; Millan, M. J.; De Nanteuil, G. Design and synthesis of potential dual NK1/NK3 receptor antagonists Bioorg. Med. Chem. Lett. 2014, 24, 510-514
7. Lu, J.-J.; Pan, W.; Hu, Y.-J.; Wang, Y.-T. Multi-target drugs: the trend of drug research and development PLoS One 2012, 7, e40262
8. Millan, M. J. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs Neurotherapeutics 2009, 6, 53
9. Wei, D.; Jiang, X.; Zhou, L.; Chen, J.; Chen, Z.; He, C.; Yang, K.; Liu, Y.; Pei, J.; Lai, L. Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching J. Med. Chem. 2008, 51, 7882
10. 3 receptor ligands J. Bioorg. Med. Chem. Lett. 2010, 20, 3405
11. Knust, H.; Nettekoven, M.; Ratni, H.; Vifian, W.; Wu, X. Piperidine derivatives as NK3 receptor antagonists. PCT Int. Appl., WO2009033995, 2009.
12. Caroon, J. M.; Dillon, M. P.; Han, B.; Nettekoven, M.; Ratni, H.; Vifian, W. Spiropiperidine Derivatives as NK3 antagonists. PCT Int. Appl., WO2008081012, 2008.
13. Bissantz, C.; Hoffmann, T.; Jablonski, P.; Knust, H.; Nettekoven, M.; Ratni, H.; Wu, X. Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists. PCT Int. Appl., WO2008128891, 2008.
14. Schnider, P. Dual NK1/NK3 antagonists against Schizophremia. PCT Int. Appl., WO2006013050, 2006.
15. Hoffmann, T.; Koblet, A.; Peters, J. U.; Schnider, P.; Sleight, A.; Stadler, H. Dual NK1/NK3 antagonists for treating schizophremia. PCT Int. Appl.,WO2005002577, 2005.
16. 3 dual antagonists for the potential treatment of schizophrenia Bioorg. Med. Chem. Lett. 2011, 21, 6899
17. Aurelio, L.; Brownlee, R. T. C.; Hughes, A. B. Synthetic preparation of N -methyl-α-amino acids Chem. Rev. 2004, 104, 5823
18. Pasternak, A.; Marino, D.; Vicario, P. P.; Ayala, J. M.; Cascierri, M. A.; Parsons, W.; Mills, S. G.; MacCoss, M.; Yang, L. Novel, orally bioavailable γ-aminoamide CC chemokine receptor 2 (CCR2) antagonists J. Med. Chem. 2006, 49, 4801
19. Shah, S. K.; Chen, N.; Guthikonda, R. N.; Mills, S. G.; Malkowitz, L.; Springer, M. S.; Gould, S. L.; DeMartino, J. A.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W. A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Emini, E. A.; MacCoss, M. Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)- butane Bioorg. Med. Chem. Lett. 2005, 15, 977
20. Dorn, C. P.; Finke, P. E.; Oates, B.; Budhu, R. J.; Mills, S. G.; MacCoss, M.; Malkowitz, L.; Springer, M. S.; Daugherty, B. L.; Gould, S. L.; DeMartino, J. A.; Siciliano, S. J.; Carella, A.; Carver, G.; Holmes, K.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Schleif, W. A.; Emini, E. A. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes Bioorg. Med. Chem. Lett. 2001, 11, 259
21. Finke, P. E.; Meurer, L. C.; Oates, B.; Mills, S. G.; MacCoss, M.; Malkowitz, L.; Springer, M. S.; Daugherty, B. L.; Gould, S. L.; DeMartino, J. A.; Siciliano, S. J.; Carella, A.; Carver, G.; Holmes, K.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Schleif, W. A.; Emini, E. A. Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: Structure-activity relationships for substituted 2-aryl-1-[ N -(methyl)- N -(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes Bioorg. Med. Chem. Lett. 2001, 11, 265
22. Hale, J. J.; Finke, P. E.; MacCoss, M. A facile synthesis of the novel Neurokinin A antagonist SR 48968 Bioorg. Med. Chem. Lett. 1993, 3, 319
23. Harvey, J. S.; Simonovich, S. P.; Jamison, C. R.; MacMillan, D. W. C. Enantioselective α-arylation of carbonyls via Cu(I)-bisoxazoline catalysis J. Am. Chem. Soc. 2011, 133, 13782
24. Bigot, A.; Williamson, A. E.; Gaunt, M. J. Enantioselective α-arylation of N -acyloxazolidinones with copper(II)-bisoxazoline catalysts and diaryliodonium salts J. Am. Chem. Soc. 2011, 133, 13778
25. Owston, N. A.; Fu, G. C. Asymmetric alkyl-alkyl cross-couplings of unactivated secondary alkyl electrophiles: stereoconvergent suzuki reactions of racemic acylated halohydrins J. Am. Chem. Soc. 2010, 132, 11908
26. Lundin, P. M.; Fu, G. C. Asymmetric Suzuki cross-couplings of activated secondary alkyl electrophiles: arylations of racemic α-chloroamides J. Am. Chem. Soc. 2010, 132, 11027
27. Andrus, M. B.; Harper, K. C.; Christiansen, M. A.; Binkley, M. A. Phase-transfer catalyzed asymmetric arylacetate alkylation Tetrahedron Lett. 2009, 50, 4541
28. Dai, X.; Strotman, N. A.; Fu, G. C. Catalytic asymmetric Hiyama cross-couplings of racemic α-bromo esters J. Am. Chem. Soc. 2008, 130, 3302
29. Krapcho, A. P.; Kuell, C. S. Mono-protected diamines. N-tert -Butoxycarbonyl-α,I-alkanediamines from α,I-alkanediamines Synth. Commun. 1990, 20, 2559
30. Krivickas, S. J.; Tamanini, E.; Todd, M. H.; Watkinson, M. Effective methods for the biotinylation of azamacrocycles J. Org. Chem. 2007, 72, 8280
31. Hughes, A. B.; Sleebs, B. E. Effective methods for the synthesis of N -methyl β-amino acids from all twenty common α-amino acids using 1,3-oxazolidin-5-ones and 1,3-oxazinan-6-ones Helv. Chim. Acta 2006, 89, 2611
32. Freidinger, R. M.; Hinkle, J. S.; Perlow, D. S.; Arison, B. H. Synthesis of 9-fluorenylmethyloxycarbonyl-protected N -alkyl amino acids by reduction of oxazolidinones J. Org. Chem. 1983, 48, 77
33. Scott, D. E.; Coyne, A. G.; Hudson, S. A.; Abell, C. Fragment-based approaches in drug discovery and chemical biology Biochemistry 2012, 51, 4990
34. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Reactifs de couplage peptidique I (1)-l′hexafluorophosphate de benzotriazolyl N -oxytrisdimethylamino phosphonium (B.O.P.) Tetrahedron Lett. 1979, 16, 1219
35. Evans, D. A.; Fu, G. C.; Hoveyda, A. H. Rhodium(I)- and iridium(I)-catalyzed hydroboration reactions: scope and synthetic applications J. Am. Chem. Soc. 1992, 114, 6671
36. Evans, D. A.; Fu, G. C.; Anderson, B. A. Mechanistic study of the rhodium(I)-catalyzed hydroboration reaction J. Am. Chem. Soc. 1992, 114, 6679
37. Dess, D. B.; Martin, J. C. A useful 12-I-5 triacetoxyperiodinane (the Dess-Martin periodinane) for the selective oxidation of primary or secondary alcohols and a variety of related 12-I-5 species J. Am. Chem. Soc. 1991, 113, 7277
38. Dess, D. B.; Martin, J. C. Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones J. Org. Chem. 1983, 48, 4155
39. Massé, J.; Langlois, N. Synthesis of 5-amino and 4-hydroxy-2-phenylsulfonylmethylpiperidines Heterocycles 2009, 77, 417
40. Hattori, K.; Sajiki, H.; Hirota, K. Pd/C(en)-Catalyzed chemoselective hydrogenation with retention of the N-Cbz protective group and its scope and limitations Tetrahedron 2000, 56, 8433
41. Boyer, N.; Gloanec, P.; De Nanteuil, G.; Jubault, P.; Quirion, J.-C. Synthesis of α,α-difluoro-β-amino esters or gem-difluoro-β-lactams as potential metallocarboxypeptidase inhibitors Eur. J. Org. Chem. 2008, 4277
42. Liu, K. G.; Robichaud, A. J. Synthesis of 3,3-disubstituted oxindoles Tetrahedron Lett. 2007, 48, 461
43. Teng, D.; Zhang, H.; Mendonca, A. An efficient synthesis of a spirocyclic oxindole analogue Molecules 2006, 11, 700
44. Bignan, G. C.; Battista, K.; Connolly, P. J.; Orsini, M. J.; Liu, J.; Middleton, S. A.; Reitz, A. B. Preparation of 3-spirocyclic indolin-2-ones as ligands for the ORL-1 receptor Bioorg. Med. Chem. Lett. 2005, 15, 5022
45. Freund, R. A convenient synthetic route to spiro[indole-3,4′- piperidin]-2-ones Helv. Chim. Acta 2000, 83, 1247
46. Clark, R. D.; Caroon, J. M.; Kluge, A. F.; Repke, D. B.; Roszkowski, A. P.; Strosberg, A. M.; Baker, S.; Bitter, S. M.; Okada, M. D. Synthesis and antihypertensive activity of 4′-substituted spiro[4 H -3,1-benzoxazine-4, 4′-piperidin]-2(1 H)-ones J. Med. Chem. 1983, 26, 657
47. Nicolaou, K. C.; Krasovskiy, A.; Trépanier, V. E.; Chen, D. Y.-K. An expedient strategy for the synthesis of tryptamines and other heterocycles Angew. Chem., Int. Ed. 2008, 47, 4217-4220
48. Pryde, D. C.; Corless, M.; Fenwick, D. R.; Mason, H. J.; Stammen, B. C.; Stephenson, P. T.; Ellis, D.; Bachelor, D.; Gordon, D.; Barber, C. G.; Wood, A.; Middleton, D. S.; Blakemore, D. C.; Parsons, G. C.; Eastwood, R.; Platts, M. Y.; Statham, K.; Paradowski, K. A.; Burt, C.; Klute, W. The design and discovery of novel amide CCR5 antagonists Bioorg. Med. Chem. Lett. 2009, 19, 1084
49. Jiang, Y.; Hong, S.-P.; Chen, B.; Eldemenky, E.; Husain, A.; Wu, L.; Lu, K.; Ma, G.; Labelle, M.; Marzabadi, M.; Sabio, M.; White, A.; Mazza, C.; Packiarajan, M. Indole Derivatives. WO/2009/120655, 2009.
50. Abdel-Magid, A. F.; Mehrman, S. J. A review on the use of sodium triacetoxyborohydride in the reductive amination of ketones and aldehydes Org. Process Res. Dev. 2006, 10, 971
51. Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D. Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. studies on direct and indirect reductive amination procedures J. Org. Chem. 1996, 61, 3849
52. Mukherjee, S.; List, B. Chiral counteranions in asymmetric transition-metal catalysis: highly enantioselective Pd/Brønsted acid-catalyzed direct α-allylation of aldehydes J. Am. Chem. Soc. 2007, 129, 11336
53. Spielvogel, D. J.; Buchwald, S. L. Nickel-BINAP catalyzed enantioselective α-arylation of α-substituted γ-butyrolactones J. Am. Chem. Soc. 2002, 124, 3500
54. Canet, J.-L.; Fadel, A.; Salaün, J. Asymmetric construction of quaternary carbons from chiral malonates: selective and versatile total syntheses of the enantiomers of α- and β-cuparenones from a common optically active precursor J. Org. Chem. 1992, 57, 3463
55. Borch, R. F.; Bernstein, M. D.; Dupont Durst, H. Cyanohydridoborate anion as a selective reducing agent J. Am. Chem. Soc. 1971, 93, 2897
56. Dourtoglou, V.; Gross, B.; Lambropoulou, V.; Zioudrou, C. O -Benzotriazolyl- N, N, N ′, N ′-tetramethyluronium hexafluorophosphate as coupling reagent for the synthesis of peptides of biological interest Synthesis 1984, 572
57. Coste, J.; Le-Nguyen, D.; Castro, B. PyBOP: a new peptide coupling reagent devoid of toxic by-product Tetrahedron Lett. 1990, 31, 205
58. Maes, V.; Tourwé, D. In Peptide and Protein Design for Biopharmaceutical Applications; Jensen, K. J., Ed.; Wiley: New York, 2009; pp 49-131
59. Gentilucci, L.; De Marco, R.; Cerisoli, L. Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization Curr. Pharm. Des. 2010, 16, 3185
60. Grauer, A.; König, B. Peptidomimetics: a versatile route to biologically active compounds Eur. J. Org. Chem. 2009, 5099